Patents by Inventor David E. Burstein

David E. Burstein has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20200129848
    Abstract: A word game played among players includes a series of word challenges having at least one round. A first round includes randomly selecting a first and a last letter, each player attempting to generate a valid word that begins with the first letter and ends with the last letter, and awarding points to each player based on a length of the corresponding valid words and a default value per letter of the valid words. A bonus round may include randomly selecting an intermediate letter, each player attempting to generate a valid bonus word that includes the first, last, and intermediate letters, awarding points to each player based at least on a length of the corresponding valid bonus words and a default value per letter of the valid bonus words, and resetting all points awarded in the word challenge for each player that fails to generate a valid bonus word.
    Type: Application
    Filed: August 31, 2016
    Publication date: April 30, 2020
    Inventors: David E. BURSTEIN, Jonah E. BURSTEIN, Isaac M. RAY
  • Publication number: 20150038596
    Abstract: This invention relates to methods of distinguishing among various types of differentiated and undifferentiated epithelial carcinomas, and non-epithelial carcinomas, by detecting the presence of p63 nucleic acid or protein expression. The invention also provides methods for detecting p63 nucleic acids and proteins, as well as methods for diagnosing and treating certain tumors based on whether the tumors express p63.
    Type: Application
    Filed: June 24, 2014
    Publication date: February 5, 2015
    Inventor: David E. Burstein
  • Publication number: 20140072969
    Abstract: This invention relates to methods of distinguishing among various types of differentiated and undifferentiated epithelial carcinomas, and non-epithelial carcinomas, by detecting the presence of p63 nucleic acid or protein expression. The invention also provides methods for detecting p63 nucleic acids and proteins, as well as methods for diagnosing and treating certain tumors based on whether the tumors express p63.
    Type: Application
    Filed: May 22, 2013
    Publication date: March 13, 2014
    Applicant: Mount Sinai School of Medicine
    Inventor: David E. Burstein
  • Patent number: 6972181
    Abstract: This invention relates to methods of distinguishing among various types of differentiated and undifferentiated epithelial carcinomas, and non-epithelial carcinomas, by detecting the presence of p63 nucleic acid or protein expression. The invention also provides methods for detecting p63 nucleic acids and proteins, as well as methods for diagnosing and treating certain tumors based on whether the tumors express p63.
    Type: Grant
    Filed: January 9, 2002
    Date of Patent: December 6, 2005
    Assignee: Mount Sinai School of Medicine of New York University
    Inventor: David E. Burstein
  • Publication number: 20020094547
    Abstract: This invention relates to methods of distinguishing among various types of differentiated and undifferentiated epithelial carcinomas, and non-epithelial carcinomas, by detecting the presence of p63 nucleic acid or protein expression. The invention also provides methods for detecting p63 nucleic acids and proteins, as well as methods for diagnosing and treating certain tumors based on whether the tumors express p63.
    Type: Application
    Filed: January 9, 2002
    Publication date: July 18, 2002
    Applicant: Mount Sinai School of Medicine of New York University
    Inventor: David E. Burstein
  • Patent number: 5897991
    Abstract: Disclosed is a method of detecting malignancy in a body cavity effusion. Also disclosed is a method of distinguishing a benign hyperplastic lymph node from a lymph node involved by a low grade follicular lymphoma. Also disclosed is a method of distinguishing a benign tumor from a malignant tumor which overexpresses GLUT-1.
    Type: Grant
    Filed: December 4, 1997
    Date of Patent: April 27, 1999
    Assignee: The Mount Sinai Medical Center
    Inventors: David E. Burstein, Richard S. Haber
  • Patent number: 5698410
    Abstract: Disclosed is a method of detecting malignancy in a body cavity effusion, Also disclosed is a method of distinguishing a benign hyperplastic lymph node from a lymph node involved by a low grade follicular lymphoma, Also disclosed is a method of distinguishing a benign tumor from a malignant tumor which overexpresses GLUT-1.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: December 16, 1997
    Assignee: Mount Sinai School of Medicine of the City University of New York
    Inventors: David E. Burstein, Richard S. Haber